<p>InspireMD, Inc.（纽约证券交易所代码：NSPR - 获取免费报告）周二的盘中交易中，股价上涨了 2%。该公司的股价最高达到 2.05 美元，最后交易价格为 2.00 美元。在交易中，共成交了 62,647 股，较平均交易量 109,290 股下降了 43%。该股票此前收盘价为 1.96 美元。</p>
<h2>InspireMD 股价上涨 2.0%</h2>
<p>该股票的 50 日移动平均线为 2.22 美元，200 日移动平均线为 2.35 美元。该股票的市值为 8474 万美元，市盈率为-2.67，贝塔值为 0.64。</p>
<h2>对 InspireMD 的对冲基金看法</h2>
<p>对冲基金最近对该公司的持仓进行了调整。Huntleigh Advisors Inc.在第二季度将其在 InspireMD 的持仓增加了 5.8%。Huntleigh Advisors Inc.目前拥有 124,228 股该公司的股票，价值 282,000 美元，在此期间又购买了 6,821 股。Raymond James Financial Inc.在第二季度将其在 InspireMD 的股份增加了 28.9%。Raymond James Financial Inc.目前拥有 44,604 股该公司的股票，价值 101,000 美元，在上个季度又购买了 10,000 股。Citadel Advisors LLC 在第三季度将其在 InspireMD 的持仓增加了 45.0%。Citadel Advisors LLC 目前拥有 37,954 股该公司的股票，价值 91,000 美元，在此期间又购买了 11,778 股。Rosalind Advisors Inc.在第二季度将其在 InspireMD 的持仓增加了 0.6%。Rosalind Advisors Inc.目前拥有 2,289,099 股该公司的股票，价值 5,196,000 美元，在此期间又购买了 14,109 股。最后，XTX Topco Ltd 在第一季度获得了 InspireMD 的新股份，价值约 38,000 美元。对冲基金和其他机构投资者持有该公司 44.78% 的股票。</p>
<h2>InspireMD 公司简介</h2>
<p>（获取免费报告）</p>
<p>InspireMD, Inc.是一家医疗设备公司，专注于 MicroNet 支架平台技术的开发和商业化，旨在治疗欧洲、拉丁美洲、中东和亚太地区的血管和冠状动脉疾病。该公司提供 CGuard 颈动脉栓塞预防系统（EPS），用于颈动脉应用；CGuard Prime 支架系统，一种网状覆盖的自扩张颈动脉支架；以及 SwitchGuard NPS，一种非侵入性的经颈动脉再血管化设备；同时还治疗伴有串联病变的急性中风。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票，而不是 InspireMD</li>
<li>3 只超市股票证明它们仍然是必需品</li>
<li>华纳兄弟出售传闻升温：投资者需要知道什么</li>
<li>宝洁公司（NYSE: PG）在不稳定的指引后回落</li>
<li>从科学项目到溶剂：WeRide 的 761% 收入激增</li>
<li>能源和石油股票解析</li>
<li>标普 500 指数在 12 月会反弹吗？这 3 个信号指向大幅波动</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 InspireMD 吗？</h2>
<p>在考虑 InspireMD 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 InspireMD 并不在名单上。</p>
<p>虽然 InspireMD 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

NSPR

<p>InspireMD 的股票（NYSE:NSPR）在午盘交易中上涨了 2%，达到了 2.05 美元的高点。尽管有所上涨，但交易量较平均水平下降了 43%。对冲基金已调整其头寸，Huntleigh Advisors、Raymond James Financial 和 Citadel Advisors 等公司显著增持。InspireMD 专注于用于血管疾病的 MicroNet 支架技术。虽然该股票获得了买入评级，但顶级分析师建议其他股票可能是更好的投资选择</p>

<p>InspireMD, Inc. (NYSE:NSPR - Get Free Report)'s stock price shot up 2% during mid-day trading on Tuesday . The company traded as high as $2.05 and last traded at $2.00. 62,647 shares traded hands during trading, a decline of 43% from the average session volume of 109,290 shares. The stock had previously closed at $1.96.</p>
<div class="lb-trans"><p>InspireMD, Inc.（纽约证券交易所代码：NSPR - 获取免费报告）周二的盘中交易中，股价上涨了 2%。该公司的股价最高达到 2.05 美元，最后交易价格为 2.00 美元。在交易中，共成交了 62,647 股，较平均交易量 109,290 股下降了 43%。该股票此前收盘价为 1.96 美元。</p>
</div><h2>InspireMD Trading Up 2.0%</h2>
<div class="lb-trans"><h2>InspireMD 股价上涨 2.0%</h2>
</div><p>The stock's 50-day moving average is $2.22 and its 200-day moving average is $2.35. The stock has a market cap of $84.74 million, a price-to-earnings ratio of -2.67 and a beta of 0.64.</p>
<div class="lb-trans"><p>该股票的 50 日移动平均线为 2.22 美元，200 日移动平均线为 2.35 美元。该股票的市值为 8474 万美元，市盈率为-2.67，贝塔值为 0.64。</p>
</div><h2>Hedge Funds Weigh In On InspireMD</h2>
<div class="lb-trans"><h2>对 InspireMD 的对冲基金看法</h2>
</div><p>Hedge funds have recently made changes to their positions in the business. Huntleigh Advisors Inc. boosted its position in InspireMD by 5.8% during the 2nd quarter. Huntleigh Advisors Inc. now owns 124,228 shares of the company's stock worth $282,000 after purchasing an additional 6,821 shares during the period. Raymond James Financial Inc. lifted its stake in shares of InspireMD by 28.9% during the second quarter. Raymond James Financial Inc. now owns 44,604 shares of the company's stock worth $101,000 after purchasing an additional 10,000 shares in the last quarter. Citadel Advisors LLC boosted its position in shares of InspireMD by 45.0% in the third quarter. Citadel Advisors LLC now owns 37,954 shares of the company's stock worth $91,000 after buying an additional 11,778 shares during the period. Rosalind Advisors Inc. boosted its position in shares of InspireMD by 0.6% in the second quarter. Rosalind Advisors Inc. now owns 2,289,099 shares of the company's stock worth $5,196,000 after buying an additional 14,109 shares during the period. Finally, XTX Topco Ltd acquired a new stake in shares of InspireMD in the first quarter valued at about $38,000. Hedge funds and other institutional investors own 44.78% of the company's stock.</p>
<div class="lb-trans"><p>对冲基金最近对该公司的持仓进行了调整。Huntleigh Advisors Inc.在第二季度将其在 InspireMD 的持仓增加了 5.8%。Huntleigh Advisors Inc.目前拥有 124,228 股该公司的股票，价值 282,000 美元，在此期间又购买了 6,821 股。Raymond James Financial Inc.在第二季度将其在 InspireMD 的股份增加了 28.9%。Raymond James Financial Inc.目前拥有 44,604 股该公司的股票，价值 101,000 美元，在上个季度又购买了 10,000 股。Citadel Advisors LLC 在第三季度将其在 InspireMD 的持仓增加了 45.0%。Citadel Advisors LLC 目前拥有 37,954 股该公司的股票，价值 91,000 美元，在此期间又购买了 11,778 股。Rosalind Advisors Inc.在第二季度将其在 InspireMD 的持仓增加了 0.6%。Rosalind Advisors Inc.目前拥有 2,289,099 股该公司的股票，价值 5,196,000 美元，在此期间又购买了 14,109 股。最后，XTX Topco Ltd 在第一季度获得了 InspireMD 的新股份，价值约 38,000 美元。对冲基金和其他机构投资者持有该公司 44.78% 的股票。</p>
</div><h2>InspireMD Company Profile</h2>
<div class="lb-trans"><h2>InspireMD 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>InspireMD, Inc, a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions.</p>
<div class="lb-trans"><p>InspireMD, Inc.是一家医疗设备公司，专注于 MicroNet 支架平台技术的开发和商业化，旨在治疗欧洲、拉丁美洲、中东和亚太地区的血管和冠状动脉疾病。该公司提供 CGuard 颈动脉栓塞预防系统（EPS），用于颈动脉应用；CGuard Prime 支架系统，一种网状覆盖的自扩张颈动脉支架；以及 SwitchGuard NPS，一种非侵入性的经颈动脉再血管化设备；同时还治疗伴有串联病变的急性中风。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than InspireMD</li>
<li>3 Grocery Stocks That Are Proving They Are Still Essential</li>
<li>Warner Bros. Sale Rumors Heat Up: What Investors Need to Know</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>From Science Project to Solvent: WeRide’s 761% Revenue Surge</li>
<li>Energy and Oil Stocks Explained</li>
<li>Will the S&amp;P 500 Rally in December? These 3 Signals Point to a Big Move Ahead</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 InspireMD</li>
<li>3 只超市股票证明它们仍然是必需品</li>
<li>华纳兄弟出售传闻升温：投资者需要知道什么</li>
<li>宝洁公司（NYSE: PG）在不稳定的指引后回落</li>
<li>从科学项目到溶剂：WeRide 的 761% 收入激增</li>
<li>能源和石油股票解析</li>
<li>标普 500 指数在 12 月会反弹吗？这 3 个信号指向大幅波动</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in InspireMD Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 InspireMD 吗？</h2>
</div><p>Before you consider InspireMD, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 InspireMD 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InspireMD wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 InspireMD 并不在名单上。</p>
</div><p>While InspireMD currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 InspireMD 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

InspireMD（NYSE:NSPR）股价上涨 2% - 你是否应该购买？